Literature DB >> 1641064

Dipeptidase activities in rat brain synaptosomes can be distinguished on the basis of inhibition by bestatin and amastatin: identification of a kyotorphin (Tyr-Arg)-degrading enzyme.

A T Orawski1, W H Simmons.   

Abstract

The neuropeptide kyotorphin (Tyr-Arg) was degraded by rat brain synaptosomes via a synaptic membrane-bound peptidase which was inhibited by bestatin but not by amastatin. The Km for kyotorphin was 8 x 10(-6) M and the Ki for bestatin was 1 x 10(-7) M. The kyotorphin-degrading enzyme was distinguished from at least one other dipeptide-hydrolyzing activity in synaptosomes which was inhibited by both bestatin and amastatin. Gel permeation chromatography of detergent-extracted synaptosomes resulted in the separation of the dipeptide-hydrolyzing activities. A single kyotorphin-degrading enzyme peak was observed which had a M(r) = 52,000. The activity peak could degrade other dipeptides including Phe-Arg, a synaptic membrane-generated metabolic of bradykinin. The kyotorphin-degrading enzyme appears to be novel and can be distinguished from other known dipeptidases on the basis of substrate specificity, subcellular localization, and inhibition profile.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1641064     DOI: 10.1007/bf00969018

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  10 in total

1.  A novel analgesic dipeptide from bovine brain is a possible Met-enkephalin releaser.

Authors:  H Takagi; H Shiomi; H Ueda; H Amano
Journal:  Nature       Date:  1979-11-22       Impact factor: 49.962

2.  The kyotorphin (tyrosine-arginine) receptor and a selective reconstitution with purified Gi, measured with GTPase and phospholipase C assays.

Authors:  H Ueda; Y Yoshihara; H Misawa; N Fukushima; T Katada; M Ui; H Takagi; M Satoh
Journal:  J Biol Chem       Date:  1989-03-05       Impact factor: 5.157

3.  Metabolism of bradykinin by multiple coexisting membrane-bound peptidases in lung: techniques for investigating the role of each peptidase using specific inhibitors.

Authors:  A T Orawski; J P Susz; W H Simmons
Journal:  Adv Exp Med Biol       Date:  1989       Impact factor: 2.622

4.  Degradation of kyotorphin by a purified membrane-bound-aminopeptidase from monkey brain: potentiation of kyotorphin-induced analgesia by a highly effective inhibitor, bestatin.

Authors:  H Ueda; G Ming; T Hazato; T Katayama; H Takagi
Journal:  Life Sci       Date:  1985-05-13       Impact factor: 5.037

5.  Separation and characterization of a dipeptidyl aminopeptidase that degrades enkephalins from monkey brain.

Authors:  T Hazato; M Inagaki-Shimamura; T Katayama; T Yamamoto
Journal:  Biochem Biophys Res Commun       Date:  1982-03-30       Impact factor: 3.575

6.  A rapid method for preparing synaptosomes: comparison, with alternative procedures.

Authors:  P R Dodd; J A Hardy; A E Oakley; J A Edwardson; E K Perry; J P Delaunoy
Journal:  Brain Res       Date:  1981-12-07       Impact factor: 3.252

7.  Regional distribution of a novel analgesic dipeptide kyotorphin (Tyr-Arg) in the rat brain and spinal cord.

Authors:  H Ueda; H Shiomi; H Takagi
Journal:  Brain Res       Date:  1980-10-06       Impact factor: 3.252

8.  Degradation of bradykinin and its metabolites by rat brain synaptic membranes.

Authors:  A T Orawski; W H Simmons
Journal:  Peptides       Date:  1989 Sep-Oct       Impact factor: 3.750

9.  Kyotorphin (tyrosine-arginine) synthetase in rat brain synaptosomes.

Authors:  H Ueda; Y Yoshihara; N Fukushima; H Shiomi; A Nakamura; H Takagi
Journal:  J Biol Chem       Date:  1987-06-15       Impact factor: 5.157

10.  Kyotorphin and D-kyotorphin stimulate Met-enkephalin release from rat striatum in vitro.

Authors:  P K Janicki; A W Lipkowski
Journal:  Neurosci Lett       Date:  1983-12-23       Impact factor: 3.046

  10 in total
  5 in total

1.  Kyotorphin transport and metabolism in rat and mouse neonatal astrocytes.

Authors:  Jianming Xiang; Huidi Jiang; Yongjun Hu; David E Smith; Richard F Keep
Journal:  Brain Res       Date:  2010-06-09       Impact factor: 3.252

2.  Comparison of antinociception induced by supraspinally administered L-arginine and kyotorphin.

Authors:  A Kawabata; S Manabe; H Takagi
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

3.  The Analgesic Activity of Bestatin as a Potent APN Inhibitor.

Authors:  Mei-Rong Jia; Tao Wei; Wen-Fang Xu
Journal:  Front Neurosci       Date:  2010-06-28       Impact factor: 4.677

Review 4.  Pharmacological Potential of the Endogenous Dipeptide Kyotorphin and Selected Derivatives.

Authors:  Juliana Perazzo; Miguel A R B Castanho; Sónia Sá Santos
Journal:  Front Pharmacol       Date:  2017-01-12       Impact factor: 5.810

5.  The Metabolic Inhibition Model Which Predicts the Intestinal Absorbability and Metabolizability of Drug: Theory and Experiment.

Authors:  Takashi Mizuma; Shoji Awazu
Journal:  Biol Proced Online       Date:  1998-05-14       Impact factor: 3.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.